Identifying vulnerabilities to immune checkpoint inhibitors of oncogene-addicted non-small cell lung cancer subgroups

被引：0
|
作者：
Diaz-Cano, Ines [1 ,2 ]
Gracia, Jose [1 ]
Cozar, Patricia [1 ]
Revuelta, Belen [1 ]
Carrizo, Nuria [1 ]
Dubrot, Juan [3 ]
Paz-Ares, Luis [1 ,2 ,4 ]
Otano, Itziar [1 ,2 ]
机构：
[1] Spanish Natl Canc Res Ctr CNIO, H12O CNIO Lung Canc Clin Res, Hlth Res Inst Hosp 12 Octubre Imas12, Madrid, Spain
[2] Spanish Ctr Biomed Res Network Oncol CIBERONC, Madrid, Spain
[3] Univ Navarra, Solid Tumors Program, Div Oncol, Ctr Appl Med Res CIMA, Pamplona, Spain
[4] Univ Complutense Madrid, Dept Med & Physiol, Madrid, Spain
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
2191 - P1.
引用
收藏
页码：792 / 792
页数：1
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis
    Guaitoli, Giorgia
    Tiseo, Marcello
    Di Maio, Massimo
    Friboulet, Luc
    Facchinetti, Francesco
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (06) : 2890 - 2916
  • [2] Oncogene-addicted non-small cell lung cancer and immunotherapy
    Tsakonas, Georgios
    Ekman, Simon
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1547 - S1555
  • [3] Role of liquid biopsy in oncogene-addicted non-small cell lung cancer
    Canale, Matteo
    Pasini, Luigi
    Bronte, Giuseppe
    Delmonte, Angelo
    Cravero, Paola
    Crino, Lucio
    Ulivi, Paola
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S265 - S279
  • [4] Is chemotherapy still an option in oncogene-addicted non-small cell lung cancer? No
    Girard, Nicolas
    BULLETIN DU CANCER, 2015, 102 (06) : S96 - S99
  • [5] Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung Cancer
    Geraud, Arthur
    Mezquita, Laura
    Auclin, Edouard
    Combarel, David
    Delahousse, Julia
    Gougis, Paul
    Massard, Christophe
    Jovelet, Cecile
    Caramella, Caroline
    Adam, Julien
    Naltet, Charles
    Lavaud, Pernelle
    Gazzah, Anas
    Lacroix, Ludovic
    Rouleau, Etienne
    Vasseur, Damien
    Mir, Olivier
    Planchard, David
    Paci, Angelo
    Besse, Benjamin
    CANCERS, 2020, 12 (12) : 1 - 13
  • [6] Immune checkpoint inhibitor treatment in patients with oncogene-addicted non-small cell lung cancer (NSCLC): summary of a multidisciplinary roundtable discussion
    Berghoff, Anna S.
    Bellosillo, Beatriz
    Caux, Christophe
    de Langen, Adrianus
    Mazieres, Julien
    Normanno, Nicola
    Preusser, Matthias
    Provencio, Mariano
    Rojo, Federico
    Wolf, Jurgen
    Zielinski, Christoph C.
    ESMO OPEN, 2019, 4 (03)
  • [7] Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer
    Listi, Angela
    Barraco, Nadia
    Bono, Marco
    Insalaco, Lavinia
    Castellana, Luisa
    Cutaia, Sofia
    Ricciardi, Maria Rita
    Gristina, Valerio
    Bronte, Enrico
    Pantuso, Gianni
    Passiglia, Francesco
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S55 - S63
  • [8] Brain Metastases in Oncogene-Addicted Non-Small Cell Lung Cancer Patients: Incidence and Treatment
    Remon, J.
    Besse, Benjamin
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [9] Acquired resistance in oncogene-addicted non-small-cell lung cancer
    Sini, Claudio
    Tuzi, Alessandro
    Rossi, Giovanni
    Russo, Alessandro
    Pezzuto, Aldo
    FUTURE ONCOLOGY, 2018, 14 (13) : 29 - 40
  • [10] Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era
    De Carlo, Elisa
    Bertoli, Elisa
    Del Conte, Alessandro
    Stanzione, Brigida
    Berto, Eleonora
    Revelant, Alberto
    Spina, Michele
    Bearz, Alessandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
12345